The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,733,986 in first-year total cost, median $198,575.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-K (54)]8
- Special Emphasis Panel[ZRG1 AARR-K (95)]1
Most frequent institutions
- BOSTON MEDICAL CENTER1
- CASE WESTERN RESERVE UNIVERSITY1
- COLLABORATIONS PHARMACEUTICALS, INC.1
- EMORY UNIVERSITY1
- GEORGE WASHINGTON UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Nef and neuroAIDS: role of cholesterol metabolism impairment and inflammation1R01NS102163-01 | BUKRINSKY, MICHAEL ILYA | GEORGE WASHINGTON UNIVERSITY, DC | $200,000 | ZRG1 |
| 2017 | Individualized approaches to the HIV/TB epidemic among polysubstance users in Irkutsk1R01DA044137-01 | HEYSELL, SCOTT K | UNIVERSITY OF VIRGINIA, VA | $199,999 | ZRG1 |
| 2017 | Social Network Intervention to Engage Community PLH to Enter HIV Medical Care1R01MH113555-01 | AMIRKHANIAN, YURI AKELLY, JEFFREY A | MEDICAL COLLEGE OF WISCONSIN, WI | $199,998 | ZRG1 |
| 2017 | ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk1R01AA025859-01 | FREIBERG, MATTHEW SSAMET, JEFFREY H. | BOSTON MEDICAL CENTER, MA | $199,648 | ZRG1 |
| 2017 | Regulatory T cell dysfunction in HIV-1/HCV drug users1R01DA044135-01 | LEDERMAN, MICHAEL MARCEL | CASE WESTERN RESERVE UNIVERSITY, OH | $198,575 | ZRG1 |
| 2017 | New therapeutic HPV vaccines for HIV infected men and women1R01CA217715-01 | PALEFSKY, JOEL MICHAEL | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $198,125 | ZRG1 |
| 2017 | New generation of non-nucleoside RT HIV inhibitors avoiding HIV-associated neurocognitive disorders1R01NS102164-01 | EKINS, SEANGARZINO-DEMO, ALFREDO | COLLABORATIONS PHARMACEUTICALS, INC., NC | $194,024 | ZRG1 |
| 2017 | Computer-based Alcohol Reduction Intervention for alcohol-using HIV/HCV+ Russian women in Clinical Care1R01AA025882-01 | DICLEMENTE, RALPH J | EMORY UNIVERSITY, GA | $187,617 | ZRG1 |
| 2017 | Defining optimal TCR-pMHC interactions: implication for designing new T-cell based therapeutics to treat viral infections and cancer1R01CA217714-01 | SYKULEV, YURI | THOMAS JEFFERSON UNIVERSITY, PA | $156,000 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.